Steward Partners Investment Advisory’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.85M Buy
87,643
+5,746
+7% +$449K 0.05% 347
2025
Q1
$5.94M Sell
81,897
-18,400
-18% -$1.33M 0.05% 348
2024
Q4
$7.42M Sell
100,297
-4,810
-5% -$356K 0.07% 289
2024
Q3
$6.94M Buy
105,107
+4,048
+4% +$267K 0.06% 293
2024
Q2
$9.33M Buy
101,059
+4,346
+4% +$401K 0.1% 207
2024
Q1
$9.24M Buy
96,713
+21,286
+28% +$2.03M 0.1% 209
2023
Q4
$5.75M Buy
75,427
+7,808
+12% +$595K 0.08% 256
2023
Q3
$4.68M Buy
67,619
+70
+0.1% +$4.85K 0.07% 270
2023
Q2
$6.37M Buy
67,549
+4,455
+7% +$420K 0.1% 223
2023
Q1
$5.22M Sell
63,094
-2,858
-4% -$236K 0.08% 244
2022
Q4
$4.92M Sell
65,952
-50,152
-43% -$3.74M 0.08% 250
2022
Q3
$9.59M Sell
116,104
-11,337
-9% -$937K 0.18% 130
2022
Q2
$12.1M Sell
127,441
-11,176
-8% -$1.06M 0.22% 110
2022
Q1
$16.3M Buy
138,617
+5,050
+4% +$594K 0.25% 89
2021
Q4
$17.3M Buy
133,567
+33,936
+34% +$4.4M 0.26% 86
2021
Q3
$11.3M Buy
99,631
+17,145
+21% +$1.94M 0.19% 125
2021
Q2
$8.54M Buy
82,486
+7,001
+9% +$725K 0.14% 153
2021
Q1
$6.31M Buy
75,485
+16,228
+27% +$1.36M 0.11% 197
2020
Q4
$5.41M Buy
59,257
+5,061
+9% +$462K 0.12% 178
2020
Q3
$4.33M Buy
54,196
+47,650
+728% +$3.8M 0.11% 199
2020
Q2
$452K Buy
6,546
+162
+3% +$11.2K 0.01% 660
2020
Q1
$401K Buy
6,384
+126
+2% +$7.91K 0.01% 617
2019
Q4
$486K Buy
6,258
+42
+0.7% +$3.26K 0.01% 631
2019
Q3
$455K Buy
6,216
+333
+6% +$24.4K 0.02% 610
2019
Q2
$362K Buy
+5,883
New +$362K 0.01% 640
2019
Q1
Sell
-4,515
Closed -$230K 801
2018
Q4
$230K Buy
4,515
+3,315
+276% +$169K 0.01% 668
2018
Q3
$70K Buy
+1,200
New +$70K ﹤0.01% 1055
2018
Q2
Sell
-819
Closed -$38K 2471
2018
Q1
$38K Sell
819
-306
-27% -$14.2K ﹤0.01% 1097
2017
Q4
$42K Buy
1,125
+102
+10% +$3.81K ﹤0.01% 885
2017
Q3
$37K Buy
1,023
+249
+32% +$9.01K ﹤0.01% 771
2017
Q2
$30K Hold
774
﹤0.01% 761
2017
Q1
$24K Buy
774
+570
+279% +$17.7K ﹤0.01% 710
2016
Q4
$6K Buy
+204
New +$6K ﹤0.01% 633